XRCC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.153610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.495200E-01
Normal-vs-Stage2
2.215000E-01
Normal-vs-Stage3
6.506400E-01
Normal-vs-Stage4
8.289000E-01
Stage1-vs-Stage2
9.324800E-01
Stage1-vs-Stage3
4.770600E-01
Stage1-vs-Stage4
6.181400E-01
Stage2-vs-Stage3
4.252200E-01
Stage2-vs-Stage4
7.265800E-01
Stage3-vs-Stage4
7.101000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.030030E-01
Normal-vs-AfricanAmerican
2.144800E-01
Normal-vs-Asian
6.013400E-01
Caucasian-vs-AfricanAmerican
3.057600E-02
Caucasian-vs-Asian
9.418600E-01
AfricanAmerican-vs-Asian
2.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.230400E-02
Normal-vs-Female
9.511400E-01
Male-vs-Female
7.377600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.747600E-01
Normal-vs-Age(41-60Yrs)
5.214000E-02
Normal-vs-Age(61-80Yrs)
5.906200E-01
Normal-vs-Age(81-100Yrs)
5.587000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.634400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.074800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.067600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.070800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.893800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.293800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.646800E-01
Normal-vs-Daily Drinker
8.407900E-02
Normal-vs-Weekly Drinker
7.272800E-01
Normal-vs-Occasional Drinker
1.002830E-01
Normal-vs-Social Drinker
7.653200E-01
Non Drinker-vs-Daily Drinker
2.977200E-01
Non Drinker-vs-Weekly Drinker
7.467600E-01
Non Drinker-vs-Occasional Drinker
2.565400E-01
Non Drinker-vs-Social Drinker
9.685400E-01
Daily Drinker-vs-Weekly Drinker
1.430190E-01
Daily Drinker-vs-Occasional Drinker
8.178200E-01
Daily Drinker-vs-Social Drinker
2.512600E-01
Weekly Drinker-vs-Occasional Drinker
1.345960E-01
Weekly Drinker-vs-Social Drinker
6.269600E-01
Occasional Drinker-vs-Social Drinker
1.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.988200E-01
Normal-vs-Grade 2
7.459000E-01
Normal-vs-Grade 3
6.607000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.625000E-01
Grade 1-vs-Grade 3
1.196350E-01
Grade 1-vs-Grade 4
4.988200E-01
Grade 2-vs-Grade 3
7.502100E-02
Grade 2-vs-Grade 4
7.459000E-01
Grade 3-vs-Grade 4
6.607000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.519200E-01
Normal-vs-NonDiabetic
5.149800E-02
Diabetic-vs-NonDiabetic
8.530200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.199200E-01
Normal-vs-NoPancreatitis
2.908600E-01
Pancreatitis-vs-NoPancreatitis
3.232600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.548400E-02
Normal-vs-N1
5.441600E-01
N0-vs-N1
6.233900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.558080E-03
Normal-vs-TP53-NonMutant
8.132400E-01
TP53-Mutant-vs-TP53-NonMutant
3.898400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
